Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125226031 | 12522603 | 1 | I | 20160620 | 20160701 | 20160701 | EXP | GB-MHRA-EYC 00141106 | GB-ACTAVIS-2016-14160 | ACTAVIS | 85.00 | YR | F | Y | 0.00000 | 20160701 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125226031 | 12522603 | 1 | PS | INDAPAMIDE. | INDAPAMIDE | 1 | Oral | 1.5 MG, DAILY | Y | UNCONFIRMED | 74722 | 1.5 | MG | PROLONGED-RELEASE TABLET | QD | ||||
| 125226031 | 12522603 | 2 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 125226031 | 12522603 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 125226031 | 12522603 | 4 | C | BETAHISTINE | BETAHISTINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125226031 | 12522603 | 5 | C | FENTANYL. | FENTANYL | 1 | Unknown | UNK | U | 0 | |||||||||
| 125226031 | 12522603 | 6 | C | ISOSORBIDE. | ISOSORBIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125226031 | 12522603 | 7 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125226031 | 12522603 | 8 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125226031 | 12522603 | 9 | C | RANITIDINE. | RANITIDINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125226031 | 12522603 | 10 | C | RIVAROXABAN | RIVAROXABAN | 1 | Unknown | UNK | U | 0 | |||||||||
| 125226031 | 12522603 | 11 | C | MOVELAT /00479601/ | 2 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125226031 | 12522603 | 1 | Product used for unknown indication |
| 125226031 | 12522603 | 2 | Product used for unknown indication |
| 125226031 | 12522603 | 3 | Product used for unknown indication |
| 125226031 | 12522603 | 4 | Product used for unknown indication |
| 125226031 | 12522603 | 5 | Product used for unknown indication |
| 125226031 | 12522603 | 6 | Product used for unknown indication |
| 125226031 | 12522603 | 7 | Product used for unknown indication |
| 125226031 | 12522603 | 8 | Product used for unknown indication |
| 125226031 | 12522603 | 9 | Product used for unknown indication |
| 125226031 | 12522603 | 10 | Product used for unknown indication |
| 125226031 | 12522603 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125226031 | 12522603 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125226031 | 12522603 | Fall | |
| 125226031 | 12522603 | Hypercalcaemia | |
| 125226031 | 12522603 | Malaise | |
| 125226031 | 12522603 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125226031 | 12522603 | 1 | 20160608 | 0 |